These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8782036)

  • 1. Renal papillary necrosis following emergency department treatment of migraine.
    Witting MD
    J Emerg Med; 1996; 14(3):373-6. PubMed ID: 8782036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the acute management of migraine and cluster headaches.
    Kumar KL
    J Gen Intern Med; 1994 Jun; 9(6):339-48. PubMed ID: 8078000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergotamine, dihydroergotamine: current uses and problems.
    Tfelt-Hansen P
    Curr Med Res Opin; 2001; 17 Suppl 1():s30-4. PubMed ID: 12463275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches.
    Klapper JA; Stanton JS
    Headache; 1991 Sep; 31(8):523-4. PubMed ID: 1960056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergency department treatment of migraine, tension, and mixed-type headache.
    Thomas SH; Stone CK
    J Emerg Med; 1994; 12(5):657-64. PubMed ID: 7989694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials.
    Friedman BW; Kapoor A; Friedman MS; Hochberg ML; Rowe BH
    Ann Emerg Med; 2008 Dec; 52(6):705-13. PubMed ID: 18632186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the emergency treatment of migraine headache.
    Lobo BL; Landy S
    J Tenn Med Assoc; 1994 Feb; 87(2):53-4. PubMed ID: 8176912
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
    Touchon J; Bertin L; Pilgrim AJ; Ashford E; Bès A
    Neurology; 1996 Aug; 47(2):361-5. PubMed ID: 8757005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
    Carleton SC; Shesser RF; Pietrzak MP; Chudnofsky CR; Starkman S; Morris DL; Johnson G; Rhee KJ; Barton CW; Chelly JE; Rosenberg J; Van Valen MK
    Ann Emerg Med; 1998 Aug; 32(2):129-38. PubMed ID: 9701293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin 1D (5-HT1D) agonists and other agents in acute migraine.
    Mathew NT
    Neurol Clin; 1997 Feb; 15(1):61-83. PubMed ID: 9058397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan.
    Pradalier A; Lutz G; Vincent D
    Headache; 2000 Apr; 40(4):324-7. PubMed ID: 10759939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P; Ricalde O; Le Force B; Saper J; Margul B
    Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble.
    Henry P; d'Allens H
    Headache; 1993 Sep; 33(8):432-5. PubMed ID: 8262783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications.
    Kelley NE; Tepper DE
    Headache; 2012 Mar; 52(3):467-82. PubMed ID: 22404708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine.
    Boureau F; Kappos L; Schoenen J; Esperanca P; Ashford E
    Int J Clin Pract; 2000 Jun; 54(5):281-6. PubMed ID: 10954953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of dihydroergotamine (DHE) should be restricted to no more than twice a week.
    Tfelt-Hansen PC; Diener HC
    Headache; 2014 Oct; 54(9):1523-5. PubMed ID: 24862945
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transformed migraine--chronic daily headache].
    Bøe MG; Monstad P
    Tidsskr Nor Laegeforen; 1999 Nov; 119(29):4311-3. PubMed ID: 10667127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine.
    Meredith JT; Wait S; Brewer KL
    Am J Emerg Med; 2003 May; 21(3):173-5. PubMed ID: 12811706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.
    Saper JR; Silberstein S
    Headache; 2006 Nov; 46 Suppl 4():S171-81. PubMed ID: 17078849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.